FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995377218> ?p ?o ?g. }

• W1995377218 endingPage "4201" @default.
• W1995377218 startingPage "4196" @default.
• W1995377218 abstract "Posaconazole oral suspension, a marketed extended-spectrum triazole with proven efficacy as antifungal treatment and prophylaxis, should be taken with food to maximize absorption. New tablet and capsule formulations have been developed in an attempt to optimize absorption and bioavailability. The aims of this exploratory open-label, partially randomized, 2-part, 4-way, single-dose crossover study in 16 healthy adults were to characterize pharmacokinetics for posaconazole tablet and capsule formulations relative to those for posaconazole oral suspension under fasted and fed conditions and to assess safety and tolerability. Under fasted conditions, posaconazole exposures (area under the curve [AUC]) for the tablet and capsule formulations were similar (mean AUC from time zero to infinity [AUC(0-∞)], tablet A, 11,700 ng · h/ml [coefficient of variation {CV}, 26%]; tablet B, 11,300 ng · h/ml [CV, 22%]; capsule, 11,000 ng · h/ml [CV, 25%]) and were substantially higher than the exposure for the oral suspension (mean AUC(0-∞), 3,420 ng · h/ml [CV, 44%]). Tablets and capsule showed less variability in exposure than the oral suspension. In fed subjects, tablets and capsule resulted in similar AUC values (mean AUC(0-∞), tablet A, 11,900 ng · h/ml [23%]; tablet B, 12,400 ng · h/ml [CV, 25%]; capsule, 12,300 ng · h/ml [CV, 28%]) and slightly higher exposure than the oral suspension (mean AUC(0-∞), 8,750 [CV, 24%]). Median times to the maximum concentration of drug in plasma were 4 to 5 h (fasted conditions) and 6 to 8 h (fed conditions). Mean half-lives values were similar for all formulations under fed and fasted conditions (23.1 to 29.2 h). Consistent with previous data, exposure for the oral suspension increased 2.5- to 3-fold when it was given with a high-fat meal. Conversely, exposures for tablets and capsule were not markedly affected by food. All formulations of posaconazole at 100 mg were safe and well tolerated." @default.
• W1995377218 created "2016-06-24" @default.
• W1995377218 creator A5004765077 @default.
• W1995377218 creator A5034764399 @default.
• W1995377218 creator A5041620286 @default.
• W1995377218 creator A5083897514 @default.
• W1995377218 date "2012-08-01" @default.
• W1995377218 modified "2023-10-14" @default.
• W1995377218 title "Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension" @default.
• W1995377218 cites W1556593209 @default.
• W1995377218 cites W1736726786 @default.
• W1995377218 cites W1981516536 @default.
• W1995377218 cites W1984228185 @default.
• W1995377218 cites W1988385266 @default.
• W1995377218 cites W1989345554 @default.
• W1995377218 cites W2011947169 @default.
• W1995377218 cites W2027445904 @default.
• W1995377218 cites W2032771458 @default.
• W1995377218 cites W2042500043 @default.
• W1995377218 cites W2071342876 @default.
• W1995377218 cites W2097822381 @default.
• W1995377218 cites W2102649824 @default.
• W1995377218 cites W2106243271 @default.
• W1995377218 cites W2117813373 @default.
• W1995377218 cites W2119544769 @default.
• W1995377218 cites W2138866540 @default.
• W1995377218 cites W2142996250 @default.
• W1995377218 cites W2155149156 @default.
• W1995377218 cites W2162626697 @default.
• W1995377218 doi "https://doi.org/10.1128/aac.00222-12" @default.
• W1995377218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3421591" @default.
• W1995377218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22615291" @default.
• W1995377218 hasPublicationYear "2012" @default.
• W1995377218 type Work @default.
• W1995377218 sameAs 1995377218 @default.
• W1995377218 citedByCount "132" @default.
• W1995377218 countsByYear W19953772182012 @default.
• W1995377218 countsByYear W19953772182013 @default.
• W1995377218 countsByYear W19953772182014 @default.
• W1995377218 countsByYear W19953772182015 @default.
• W1995377218 countsByYear W19953772182016 @default.
• W1995377218 countsByYear W19953772182017 @default.
• W1995377218 countsByYear W19953772182018 @default.
• W1995377218 countsByYear W19953772182019 @default.
• W1995377218 countsByYear W19953772182020 @default.
• W1995377218 countsByYear W19953772182021 @default.
• W1995377218 countsByYear W19953772182022 @default.
• W1995377218 countsByYear W19953772182023 @default.
• W1995377218 crossrefType "journal-article" @default.
• W1995377218 hasAuthorship W1995377218A5004765077 @default.
• W1995377218 hasAuthorship W1995377218A5034764399 @default.
• W1995377218 hasAuthorship W1995377218A5041620286 @default.
• W1995377218 hasAuthorship W1995377218A5083897514 @default.
• W1995377218 hasBestOaLocation W19953772181 @default.
• W1995377218 hasConcept C112705442 @default.
• W1995377218 hasConcept C142724271 @default.
• W1995377218 hasConcept C16005928 @default.
• W1995377218 hasConcept C181389837 @default.
• W1995377218 hasConcept C185592680 @default.
• W1995377218 hasConcept C197934379 @default.
• W1995377218 hasConcept C204787440 @default.
• W1995377218 hasConcept C27081682 @default.
• W1995377218 hasConcept C2777071850 @default.
• W1995377218 hasConcept C2778375690 @default.
• W1995377218 hasConcept C2778566413 @default.
• W1995377218 hasConcept C2778778583 @default.
• W1995377218 hasConcept C2779548794 @default.
• W1995377218 hasConcept C43617362 @default.
• W1995377218 hasConcept C59822182 @default.
• W1995377218 hasConcept C71924100 @default.
• W1995377218 hasConcept C76318530 @default.
• W1995377218 hasConcept C77281830 @default.
• W1995377218 hasConcept C86803240 @default.
• W1995377218 hasConcept C87813604 @default.
• W1995377218 hasConcept C98274493 @default.
• W1995377218 hasConceptScore W1995377218C112705442 @default.
• W1995377218 hasConceptScore W1995377218C142724271 @default.
• W1995377218 hasConceptScore W1995377218C16005928 @default.
• W1995377218 hasConceptScore W1995377218C181389837 @default.
• W1995377218 hasConceptScore W1995377218C185592680 @default.
• W1995377218 hasConceptScore W1995377218C197934379 @default.
• W1995377218 hasConceptScore W1995377218C204787440 @default.
• W1995377218 hasConceptScore W1995377218C27081682 @default.
• W1995377218 hasConceptScore W1995377218C2777071850 @default.
• W1995377218 hasConceptScore W1995377218C2778375690 @default.
• W1995377218 hasConceptScore W1995377218C2778566413 @default.
• W1995377218 hasConceptScore W1995377218C2778778583 @default.
• W1995377218 hasConceptScore W1995377218C2779548794 @default.
• W1995377218 hasConceptScore W1995377218C43617362 @default.
• W1995377218 hasConceptScore W1995377218C59822182 @default.
• W1995377218 hasConceptScore W1995377218C71924100 @default.
• W1995377218 hasConceptScore W1995377218C76318530 @default.
• W1995377218 hasConceptScore W1995377218C77281830 @default.
• W1995377218 hasConceptScore W1995377218C86803240 @default.
• W1995377218 hasConceptScore W1995377218C87813604 @default.
• W1995377218 hasConceptScore W1995377218C98274493 @default.
• W1995377218 hasIssue "8" @default.
• W1995377218 hasLocation W19953772181 @default.

• next